These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1710695)
1. [The use of immunochemical reactions in determining a cytological diagnosis]. Shabalova IP; Pugachev KK; Shimbireva IB; Rudneva EA Lab Delo; 1990; (12):49-52. PubMed ID: 1710695 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma. Mezger J; Lamerz R; Permanetter W J Thorac Cardiovasc Surg; 1990 Dec; 100(6):860-6. PubMed ID: 2147220 [TBL] [Abstract][Full Text] [Related]
3. [Concentrations of carcinoembryonic antigen and ferritin in pleural and ascitic effusion of various origins]. Stabellini G; Trevisani L; Sartori S; Pazzi P Gastroenterol Clin Biol; 1985; 9(6-7):543-5. PubMed ID: 4018490 [No Abstract] [Full Text] [Related]
4. [Clinical evaluation of various tumor markers in pleural effusion and in the serum]. Jibiki K; Abe Y; Takeda M; Iwachika C; Odagiri E; Demura R; Demura H Gan No Rinsho; 1989 Aug; 35(9):991-8. PubMed ID: 2769951 [TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical staining of cells in 153 pleural effusions with a panel of monoclonal antibodies and lectins. Abramenko IV; Gluzman DF; Sklyarenko LM; Pisnyachevskaya GV; Pinchouk VG Anticancer Res; 1991; 11(2):629-34. PubMed ID: 1712178 [TBL] [Abstract][Full Text] [Related]
7. [Diagnostic criteria for the tumor markers of the body fluids]. Konishi K; Nakagawa S; Watanabe K; Takamura S Rinsho Byori; 1983 Sep; 31(9):945-54. PubMed ID: 6198536 [No Abstract] [Full Text] [Related]
8. [A clinical study on CEA, TPA, ADA, ferritin, beta 2 microglobulin and sialic acid levels in pleural effusion]. Reshad K; Suzuki K; Itoi K; Takahashi Y; Hirata T; Yagi T; Sato A; Nakano Y Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Nov; 25(11):1174-80. PubMed ID: 3329690 [No Abstract] [Full Text] [Related]
9. [Immunocytochemical studies of epithelial markers in pleural and peritoneal effusions as an adjunct to cytologic diagnosis]. Lossnitzer A; Sturm U; Kaltschmidt A; Zotter S Zentralbl Allg Pathol; 1988; 134(6):539-45. PubMed ID: 3213287 [TBL] [Abstract][Full Text] [Related]
10. The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology. Sari R; Yildirim B; Sevinc A; Bahceci F; Hilmioglu F Hepatogastroenterology; 2001; 48(42):1616-21. PubMed ID: 11813585 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of three tumor markers determined in pleural effusions. Conejo JR; Benedito JE; Jimenez A; Menchen M; Cano J; Granizo V; Larrodera L Eur J Clin Chem Clin Biochem; 1996 Feb; 34(2):139-42. PubMed ID: 8833646 [TBL] [Abstract][Full Text] [Related]
12. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions. Friedman MT; Gentile P; Tarectecan A; Fuchs A Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609 [TBL] [Abstract][Full Text] [Related]
13. Use of a panel of markers in the differential diagnosis of adenocarcinoma and reactive mesothelial cells in fluid cytology. Ko EC; Jhala NC; Shultz JJ; Chhieng DC Am J Clin Pathol; 2001 Nov; 116(5):709-15. PubMed ID: 11710688 [TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical differentiation of reactive mesothelial cells and adenocarcinoma cells in serous effusions with the use of carcinoembryonic antigen and fibronectin. Athanassiadou P; Athanassiades P; Lazaris D; Kyrkou K; Petrakakou E; Aravantinos D Acta Cytol; 1994; 38(5):718-22. PubMed ID: 8091904 [TBL] [Abstract][Full Text] [Related]
15. The cytologic application of carcinoembryonic antigen for the discrimination of malignant from benign serous effusions. Kyrkou KA; Iatridis SG; Athanassiadou PP; Athanassiadis PP; Mandragos CE Cancer Detect Prev; 1985; 8(1-2):247-54. PubMed ID: 4064045 [TBL] [Abstract][Full Text] [Related]
16. Comparison of three cytologic preparation methods and immunocytochemistries to distinguish adenocarcinoma cells from reactive mesothelial cells in serous effusion. Ueda J; Iwata T; Ono M; Takahashi M Diagn Cytopathol; 2006 Jan; 34(1):6-10. PubMed ID: 16355377 [TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids. Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338 [TBL] [Abstract][Full Text] [Related]